OpGen, Inc.
$23.91▲ 64.36%(+$9.75)
TickerSpark Score
78/100
▌ Solid
80
Valuation
100
Profitability
60
Growth
52
Health
100
Momentum
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a OPGN research report →
52-Week Range70% of range
Low
$0.00
Current
$23.91
High
$34.00
Company Overviewwww.opgen.com
About the company
OpGen, Inc. is a precision medicine company dedicated to developing and commercializing advanced molecular microbiology solutions for both U. S.
- CEO
- Christian-Laurent Benoit Bonte
- IPO
- 2015
- Employees
- 85
- HQ
- Rockville, MD, US
Price Chart
+460.98% · this period
Valuation
- Market Cap
- $242.67M
- P/E
- 7.14
- P/S
- 5.75
- P/B
- 6.24
- EV/EBITDA
- 7.23
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 89.99%
- Op Margin
- 78.63%
- Net Margin
- 77.21%
- ROE
- 111.12%
- ROIC
- 71.83%
Growth & Income
- Revenue
- $30.20M · 481.20%
- Net Income
- $23.62M · 96.95%
- EPS
- $2.33 · -4.51%
- Op Income
- $24.03M
- FCF YoY
- 75.69%
Performance & Tape
- 52W High
- $34.00
- 52W Low
- $0.00
- 50D MA
- $22.24
- 200D MA
- $8.61
- Beta
- -1.93
- Avg Volume
- 5.58K
Get TickerSpark's AI analysis on OPGN
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Coverage · OPGN
Our OPGN coverage
Recent articles, reports, and earnings notes.
On-Demand Research
No research on OPGN yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate OPGN report →Internal Compare
Similar companies
Peers in the same neighborhood.